Development and Validation of Glimepiride and Metformin in Human Plasma by HPLC: An application study
DOI:
https://doi.org/10.7439/ijapa.v5i3.2433Keywords:
RP - HPLC, Glimepiride, Metformin, Human plasmaAbstract
A simple and cost effective RP-HPLC method is developed for simultaneous estimation of glimepiride (GLIM) and metformin (MET) at tablet dosage form using C-18 column (4.6 x 250mm, 5?, 100 A?) with a mobile phase composed ofmethanol: water (90:10% v/v) buffered with ortho phosphoric acid at a flow rate of1.0 mL/min (UV detection at 231 nm). The retention time of both drugs (GLIM and MET) are observed as 4.286 and 2.262 respectively. Human plasma spiking studies of both the API and the formulation at the concentration of (0.2g/mL - 1g/mL) for glimepiride and metformin (1g/mL - 5g/mL) expresses the standard correlation coefficients of 0.9998 and 0.9999 respectively for API and 0.9917 and 0.99 respectively for the tablet dosage form. The mean (%) recoveries of glimepiride and metformin are 99.98 and 99.9% respectively. The % RSD below 0.5 shows the high precision of the proposed method. Assay studies revealed that 98.05% of purity is observed for glimepiride and 99.69 for metformin in a tablet dosage form. Human plasma spiking studies revealed that a minimal quantum of glimepiride had been bound with the plasma proteins compare to metformin in the tablet dosage form. The method was validated as per the ICH guidelines.Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2016 International Journal of Advances in Pharmaceutical Analysis

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
a) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
b)Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
After acceptance of the article, the author has to submit copyright form signed by all authors.